Keywords: Alzheimer's Disease, Alzheimer's DiseaseAmyloid Related Imaging Abnormality (ARIA) was reported in 40% of patients treated with anti-amyloid beta drugs in phase 3 trials. It is expected to be a significant factor in the clinical application of new Alzheimer’s Disease (AD) modifying therapies and requires standardized and practical imaging. By employing Compressed-SENSE (CS-SENSE) and newer deep learning based SmartSpeed to accelerate acquisition we created a robust MRI protocol that can be completed in under ten minutes without loss of any image quality. This accelerated protocol can provide a clinically feasible strategy for scanning large populations.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords